论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Qin Z, Liu X
Received 8 July 2018
Accepted for publication 19 September 2018
Published 22 January 2019 Volume 2019:12 Pages 749—751
DOI https://doi.org/10.2147/OTT.S179501
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Andrew Yee
Peer reviewer comments 2
Editor who approved publication: Dr Samir Farghaly
Abstract: Recently,
miR-124 has been regarded as a critical modulator of colorectal cancer.
We here summarize the studies on the role and mechanism of miR-124 in
colorectal cancer. They indicate that miR-124 is methylated during
carcinogenesis and functions as a tumor-suppressor in colorectal cancer.
miR-124 might serve as a potential diagnostic biomarker and therapeutic target
in colorectal cancer in the foreseeable future.
Keywords: miR-124,
colorectal cancer, biomarker, methylation, therapeutic target
